HIK fundamentals
HIKMA PHARMACEUTICALS PLC financial statements, including revenue, expenses, and profit
The total revenue of HIK for the last semiannual is 1.54 B USD, and it's 1.70% lower compared to the previous semiannual. The net income of H2 24 is 131.66 M USD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
TTM